Lipid droplets are dynamic organelles that can be found in most eukaryotic and certain prokaryotic cells. Structurally, the droplets consist of a core of neutral lipids surrounded by a phospholipid monolayer. One of the most useful techniques in determining the cellular roles of droplets has been proteomic identification of bound proteins, which can be isolated along with the droplets. Here, two methods are described to isolate lipid droplets and their bound proteins from two wide-ranging eukaryotes: fission yeast and human placental villous cells. Although both techniques have differences, the main method -density gradient centrifugation -is shared by both preparations. This shows the wide applicability of the presented droplet isolation techniques.
Introduction
Cellular lipid droplets are dynamic organelles that serve multiple functions in cells. They are storage hubs for neutral lipids, which can be converted into energy or used for phospholipid synthesis. The droplets play central roles in physiological and pathological conditions including atherosclerosis, obesity and related metabolic diseases, and also infectious diseases 1, 2 . In addition, they are intriguing sources for biodiesel fuels.
Much information on the cellular roles of lipid droplets has been obtained from proteomic and lipidomic analysis of droplets purified from wideranging organisms 3 . These organisms have included bacteria 4, 5 , yeast [6] [7] [8] [9] [10] [11] , plants 12, 13 , nematodes 14 , and flies 15, 16 . Given the interest in the role of lipid droplets in human metabolic diseases, droplets have also been isolated from cultured animal cells and animal tissues. Cultured cell lines have included 3T3-L1 adipocytes 8 . Gently transfer the top floating white layer (Figure 2A) , which contains the droplets, to a new centrifuge tube(s) using either a pipettor or a bent Pasteur pipette. Add enough volume of 12% Ficoll, 10 mM Tris-HCl, and 200 μM EDTA buffer to the sample so that it fills roughly onethird of the centrifuge tube. 9. Add the equivalent volume of 8% Ficoll, 10 mM Tris-HCl, and 200 μM EDTA buffer to the top of the sample(s) in the new centrifuge tube(s).
After addition of this buffer the tubes should be about two-thirds full. 10. Centrifuge at 4 °C at 100,000 x g for 1 hr in an SW28 rotor or equivalent. Allow rotor to coast to a stop (rotor deceleration = 0). 11. Gently transfer the top floating white layer (Figure 2B ), which will contain the droplets, to a new centrifuge tube(s) using either a pipettor or a bent Pasteur pipette. Add 600 mM sorbitol, 8% Ficoll, 10 mM Tris-HCl, and 200 μM EDTA buffer to the sample so that it fills about one-third of the centrifuge tube. 12. Add the equivalent volume of 250 mM sorbitol, 10 mM Tris-HCl, and 200 μM EDTA buffer to the top of the sample(s) in the new centrifuge tube(s). After addition of this buffer the tubes should be about two-thirds full. 13. Centrifuge at 4 °C at 100,000 x g for 1 hr in an SW28 rotor or equivalent. Allow rotor to coast to a stop (rotor deceleration = 0). 14. Transfer top white layer (Figure 2C) , which should contain only the lipid droplets and bound proteins, to dialysis tubing, and dialyze O/N into 10 mM Tris-HCl and 200 μM EDTA buffer to eliminate the Ficoll.
Isolating Lipid Droplets from Human Placental Villous Cells
Placentas were collected from healthy women with singleton pregnancies undergoing elective cesarean section delivery prior to the onset of spontaneous labor at term. Subjects gave written, informed consent for the collection of their placenta. The collection, and subsequent use, of placentas was performed with approval from the University of Tennessee and University of Tennessee Graduate School of Medicine in Knoxville Institutional Review Board (#8757B and #3338, respectively).
Isolating human placental villous cells
Part 1 of the protocol is a modification of an earlier published protocol by Petroff et al.
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Prepare following solutions:
• NaCl (1 L): dissolve 9 g NaCl (M 58. • Enzyme digestion buffer (0.6 ml): combine 70 ml 10x HBSS with 3.3 ml 7.5% Na Biscarbonate, 17.5 ml 1 M HEPES, and 266.1 ml dH 2 O; filter sterilize (0.2 μm membrane). Store at 4 °C. • DNase I: just before use, add 5 ml sterile 0.9% NaCl to a vial of DNase. Keep on ice until use or store at -20 °C.
6. After collecting the cells from all three digestion stages, filter the suspension using a 100 μm Nylon cell strainer inserted in the top of a sterile 50 ml conical centrifuge tube. If the filtration of the cell suspension slows, lift upward on the filter to draw a vacuum within the tube. 7. Centrifuge at 4 °C at 1,000 x g for 10 min. Carefully remove supernatant without disturbing the pellet.
Homogenizing placental villous cells
1. Before starting with the isolation process, prepare 50 ml of Hypotonic Lysis Medium (HLM) containing 20 mM Tris-HCl, pH 7.4 and 1 mM EDTA. Add protease inhibitors to HLM just before use and keep the medium on ice. 2. In the biological safety hood, add 4 times the cell pellet volume of ice-cold HLM to the cells. Gently and thoroughly resuspend the cells by pipetting the cells up-and-down using a 10 ml pipette. 3. Incubate the suspended cells on ice for 10 min. 4. Transfer the cells to the Dounce homogenizer, which should be on ice. Slowly homogenize the cells by applying 20-25 gentle strokes with the loose-fitting pestle of the homogenizer. 5. Centrifuge the cell lysate at 4 °C at 3,000 x g for 10 min to remove unbroken cells, cellular debris and nuclei. 6. Collect the supernatant and transfer to a SW28 tube (or alternative that can be centrifuged at 25,000 x g). Centrifuge at 4 °C at 25,000 x g for 20 min to remove the mitochondria.
Isolating lipid droplets by ultracentrifugation
1. Prepare 50 ml of 100 mM sodium carbonate (M 106 g/mol) buffer (pH 11.5) and 50 ml of 60% sucrose (w/w) solution. Add protease inhibitors to the sodium carbonate buffer just before use and keep on ice. 2. Collect the supernatant from step 2.6 into a 50 ml centrifuge tube, adjust to 20% of sucrose and transfer into the bottom of an ultracentrifuge tube for an SW28 rotor, or equivalent. Overlay density adjusted supernatant with ~10 ml of ice-cold 100 mM sodium carbonate buffer (pH 11.5) and 0.5-1 ml of ice-cold HLM to fill the tube. 3. Centrifuge at 4 °C at 130,000 x g for 45 min using SW28 swinging bucket rotor. Allow rotor to coast to a stop (rotor deceleration = 0). 4. Collect the floating layer, adjust to 10% sucrose and transfer into the bottom of a 13.2 ml ultracentrifuge tube for an SW41Ti rotor, or equivalent. Overlay density adjusted supernatant with about 5 ml of ice-cold 100 mM sodium carbonate buffer (pH 11.5) and 0.5 ml of icecold HLM. 5. Centrifuge at 4 °C at 274,000 x g for 60 min using SW41Ti swinging bucket rotor. Allow rotor to coast to a stop (rotor deceleration = 0) to minimize disruption of the lipid droplet layer. 6. Carefully collect the top floating layer ( Figure 2D ) containing lipid droplets with a 1 ml pipette and repeat step 3.4. 7. Centrifuge at 4 °C at 274,000 x g for 30 min using SW41Ti swinging bucket rotor. Allow rotor to coast to a stop (rotor deceleration = 0). 8. Carefully collect the top white-colored floating layer containing lipid droplets with a bent Pasteur pipette into three 1.5 ml tubes containing 100 μl HLM.
Characterizing lipid droplets fraction (Protocols 1 and 2)
The recovery and purity of the lipid droplet fraction can be verified by Western Blot combined with light or electron microscopy. In addition, aliquots after different centrifugation steps can be collected and retained for determining purification efficiency. In Western Blotting, it is more appropriate to compare a volume of the lipid droplet fraction that represents an equivalent of the whole cell lysate than comparing lipid droplets to other membrane fractions on the basis of total protein content 24 .
Representative Results
If the density gradient centrifugation worked as expected, the floating layer should contain lipid droplets and be depleted of other organelles throughout the progression of the high-speed spins.
For Protocol 1, Western Blots were performed with marker antibodies to lipid droplets (Erg6p), and organelles that have been found to interact with lipid droplets in yeast, ER (Dpm1p), mitochondria (Por1p), plasma membrane (Pma1p), and vacuoles (Vma1p).
Equal volumes of the floating layer of each three spins (steps 3.7, 3.10, and 3.13) were collected, precipitated with trichloroacetic acid (15% final concentration), and solubilized in water. 13 ml of the cell lysate ( Figure 3A , "Lys") and protein prep of each three spins ( Figure 3A , "Spin1", "Spin2", and "Spin3") were separated on 12% SDS-PAGE, transferred to nitrocellulose membrane, and immunoblotted with organelle specific antibodies. As expected, the lipid droplet marker protein Erg6p is present in the floating layer after each of the three spins ( Figure 3A) ; Por1p is not present in the floating layer after Spin1 ( Figure 3A) ; Vma1p is depleted from the floating layer after Spin2 ( Figure 3A) ; and Dpm1p and Pma1p are not present in the floating layer after Spin3 ( Figure 3A) .
For Protocol 2, the presence of lipid droplets isolated from human term placental villous cells was verified by staining with a neutral lipid specific fluorescence dye, BODIPY 493/503. The droplets were then visualized under a fluorescence microscope ( Figure 3B ). The purity of the isolated lipid droplet fractions was evaluated by Western Blotting with marker proteins for lipid droplets (perilipin 2), ER (calnexin), Golgi (GM130), mitochondria (COX IV) and plasma membrane (MEK1) (Figure 3C ). The lipid droplets were de-lipidated with cold acetone and the proteins were extracted. Equal percentages of post-nuclear supernatant (PNS), the fraction beneath the floating layer of the last spin (step 3.6, "Spin4" on Figure 3C ), the subsequent wash step (step 3.8, "Spin5" on Figure 3C ), and de-lipidated protein prep of floating lipid droplet layer (step 3.8, "LD" on Figure 3C ) were separated on 12% SDS-PAGE, transferred and immunoblotted with indicated antibodies. Perilipin 2 (also known as ADRP), the lipid droplet protein, was detected in post-nuclear supernatant and in the isolated white floating layer containing lipid droplets. Proteins specific for plasma membrane (MEK1) and Golgi (GM130) were not detected in lipid droplet fractions in either layer beneath the floating layer for Spin4 and Spin5. As previously reported, the ER protein calnexin 18, 27, 28 . Therefore, the media in which the cells are grown and the density of the cells should be closely monitored before lysis.
The protein composition of lipid droplets is a function of the growth phase of the yeast cells. Fewer proteins will be bound to the droplets in log growth phase versus stationary phase. Also, spheroplasting efficiency is a function of the growth phase of the yeast cells. Cells in log growth phase will have higher yields of spheroplasts than cells in stationary phase because the latter are more resistant to enzymatic treatment.
Make sure to use gentle techniques to break open the cells.
Techniques that break down the yeast cell wall by enzymatic digestion are preferred over techniques that rupture the cell wall through applied force. The latter method may disrupt the structural integrity of the droplets resulting in loss of bound proteins or lipids.
Avoid freezing samples after the cells have been lysed. Freezing droplets is not recommended because it can affect their structural integrity resulting in the loss of bound protein or lipids. Freezing could also cause the droplets to fuse or fragment 24 . This may be especially relevant since droplets have been observed to fragment or undergo fission in live yeast cells 25 and thus breakdown of larger droplets into smaller ones is possible. Pieces of droplets that fragment may not have the buoyancy to appear in the floating layer during density gradient centrifugation. This could artificially reduce the number of droplet factors that would be identified by this technique since the protein composition of droplet surfaces may be a function of droplet size 32 .
Make sure to test the localization of lipid droplet associated factors to lipid droplets. One of the characteristics of lipid droplets is that they interact with other organelles [33] [34] [35] [36] [37] . Therefore, factors from these organelles are often found in the lipid droplet fraction. Therefore, it is important to use additional techniques to ensure that these factors localize to the droplets. Studies with a fluorescent fusion protein linked to the protein of interest in cells where the lipid droplets are stained with a different fluorescent marker should be used to determine the extent of colocalization 15 .Techniques such as protein correlation profiling can be used to further quantify the purity of the lipid droplet fraction 15 . In that strategy, two components are each labeled with different isotope-containing amino acids. The first component is a known lipid droplet factor, and the second component is the fraction that is being analyzed. Comparisons are then made between the fractional locations of the two components.
Modifications and troubleshooting
Modifications to Protocol 1 for isolating lipid droplets from the budding yeast Saccharomyces cerevisiae are noted. Note that the sizes of lipid droplets can vary greatly. Density gradient centrifugation speeds may need to be increased for smaller droplets to accumulate in the floating layer.
Limitations of the technique
Access to an ultra centrifuge with a swinging bucket rotor is essential for the isolation of cellular lipid droplets. Although this piece of equipment is standard in most cell biology and biochemistry laboratories, it is expensive.
Significance of the technique with respect to existing methods or other alternative methods
As mentioned above, Protocol 1 is closely based on the work of Leber et al. 6 and part 1 of Protocol 2 is a modification of an earlier published protocol by Petroff et al.
26

Applications
Lipid droplet isolation is most useful for subsequent proteomic and lipidomic analysis of bound proteins, neutral lipids and phospholipids. Inventories of lipid droplet associated proteins and lipids have been compiled 4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] 19, 20, 22, 23, 28 .
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